Inclusion Criteria:  Meet the diagnostic criteria of insomnia; TCM syndrome differentiation belongs to deficiency of both heart and spleen; Male or female participants aged 18-75; Participants whose PSQI score is 5-15; The course of disease is more than 3 months; Participants who voluntarily agree with the investigation and sign a written informed consent form for the clinical trial.  Exclusion Criteria:  Participants with mental retardation; Participants with serious cardiovascular diseases, liver, kidney and hematopoietic system diseases; Insomnia is caused by nervous system diseases (such as stroke, Parkinson's disease) or mental disorders (including depression or anxiety); Female participants who is pregnant or lactating; Participants with diabetes and sensory dysfunction. Participants with skin diseases of acupoints; Taking sedative hypnotics (including barbiturates, benzodiazepines, tranquilizers, diphenylmethane, etc) and other insomnia related drugs within 2 weeks before the trial; Participants with dependence on sleeping drugs; Participants suffering from malignant tumor, sequelae of severe cerebral apoplexy, organ failure and other major diseases that affect insomnia and therapeutic effect.